MODENA HOSPITAL’S INNOVATIVE INTEGRATED THERAPY PROGRAMME FOR BLOOD CANCER PATIENTS

The integrated Programme of Advanced Cell Therapies and Care run by the University Hospital (AOU) in Modena, supported by Fondazione Iris Ceramica Group, has brought positive results for the care of blood cancer patients.

MODENA HOSPITAL’S INNOVATIVE INTEGRATED THERAPY PROGRAMME FOR BLOOD CANCER PATIENTS

The project run by the AOU in Modena, also with the support of Fondazione Iris Ceramica Group, consists in a Programme of Advanced Cell Therapies for patients with acute leukaemia, lymphomas and multiple myeloma (and their infectious complications) integrated with a new Intra-Hospital Early Supportive/Palliative Care Programme for blood cancer patients.

The project – which has been guaranteed continuity despite the difficulties caused by the Covid-19 health emergency – has brought significant benefits:

- In-service training for medical staff to improve their ability to provide innovative cell therapies to patients, supported by a new model of supportive/palliative care

- Development of research projects able to validate the expected benefits of integrated therapies, which translates into greater effectiveness of medical interventions and quality of life for the patients and their families

- Quality care in terms of advanced diagnosis, innovative therapy and support

- More effective communication between medical staff and patients

The results of the project are given in the reports produced by the Haematology Department, UNIMORE and the AOU in Modena.

These results confirm the value of the commitment of Fondazione Iris Ceramica Group to supporting health and social initiatives, to guarantee suitable care for blood cancer patients.